Brian Nowosielski

NCPDP joined the Total Pharmacy Solutions Summit event as the keynote session, addressing whether community pharmacy is facing a “Tower Records problem.”

Mike Johnston, CPhT-Adv, CEO of NPTA, detailed how independent pharmacies can transform their staffing from a chronic shortage into a high-performing engine.

The Total Pharmacy Solutions Summit Summer 2026 concluded with a powerful call to action for community pharmacies looking to balance policy, people, and profitability.

Justin Macy, PharmD, JD, and Andrew Funk, PharmD, of NABP, emphasize that compliance is a critical safeguard against the rising threat of counterfeit and illegitimate products.

Pharmacy reimbursement stability is built on transparency, financial visibility, and an understanding of upcoming industry shifts.

Experts explore artificial intelligence in PBM-pharmacy relationships and how the technology may impact sustainability.

Lucas Morgan, Esq, and Dae Lee, PharmD, Esq, CPBS, present on the significant opportunities and regulatory risks surrounding compounded peptides and GLP-1 products in 2026.

Kevin Boesen, PharmD, delivers a session on turning Medicare policy shifts into tangible revenue and workflow efficiency for community pharmacies.

As PBM-pharmacy relationships evolve in real time, staying proactive when a PBM audit comes through could be the difference between thriving and losing essential business.

The pneumococcal vaccine is approved for protection against 21 serotypes in adults over 18 and children between 2 and 17 at high risk of disease.

Through transformational, authentic, servant, and distributed models, researchers explore the impact of leadership on the pharmacy workforce.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Alyssa Perry, PharmD to discuss the pharmacist’s role in ensuring inclusive and respectful care for members of the LGBTQ+ community.

GSK and Spero Therapeutics’ newly approved carbapenem could be a standard of care in adults with complicated urinary tract infections who prefer oral administration.

In part 2, Harini Bupathi, Esq, dives deeper into PBMs’ goals behind pharmacy audits and how that could all change with recent reform measures.

As health care spending and polypharmacy increase, researchers are exploring new ways to deprescribe medications, looking to pharmacists to fill in a gap.

Community pharmacies have become one of the most accessible points of care for patients, especially in rural and underserved communities.

With continued reports of gradually waning efficacy among pneumococcal vaccines, researchers look toward vaccine effectiveness among patients aged 18 to 64 years.

Harini Bupathi, Esq, discusses the basis of PBM audits, why they exist, and how pharmacies can anticipate them.

With social determinants of health impacting patient outcomes, researchers assess the viability of community pharmacy partnerships for addressing atrial fibrillation.

In a recent PSG-sponsored webinar, experts present on the growing push toward new-wave pharmacy benefit managers models in pharmacy benefits design.

As clinical roles expand, the need for robust pharmacy infrastructure to streamline workflows and ensure medication access has never been more critical.

Despite the boom in prescription weight loss medications, the management of OTC alternatives is still paramount in improving patient outcomes and reducing adverse events.

In part 2 of our interview with Julia Vu, PharmD, she delves into the AI space within pharmacy practice while touching on the industry’s role in boosting rural health outcomes.

Reports state that everyone from “shadowy online vendors” to physicians and nurses is illegally promoting the drug before it receives proper FDA approval.

This episode explores the true price of commitment to a dream or vision, explaining how anything less than full dedication can lead to failure and why small wins are essential for perseverance.

Alongside malnutrition instances and measles cases, researchers review pneumonia disease burden and immune vulnerability across high-risk pediatric groups.

Based on data from the ADA’s 2026 Scientific Sessions, glucagon-like peptide-1s are continuing to revolutionize the cardiometabolic disease landscape.

Julia Vu, PharmD, joins to discuss industry-impacting NCPDP standards and how they are introducing new processes for medication delivery.

As pneumococcal disease continues to rise since the COVID-19 pandemic, researchers looked at the need to escalate the management of serotype surveillance and vaccine coverage.

The AI-led initiative was designed to conduct audits and ensure appropriate distribution of health care funds for federal programs.